In conclusion, we demonstrated the presence of IL-17A+ cells, which were mainly lymphocytes, in clinically early visible inflamed acne lesions, and also the activation of cytokines, chemokines and antimicrobial peptides known to be typical for the Th17/IL-17 pathway. The gene discussed is IL17A; the disease is acne.